← Eichor
Condition: Pancreatic Intraductal Neoplasms Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Pancreatic Intraductal Neoplasms

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Identification of New Theranostic Biomarkers of Pancreatic Tumor Progression
Phase N/A · 2 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT06574373
Integration of Multiomics Markers for Invasive IPMNs Identification Through the Set-up of the INvasive Cyst bIomarkers D
Phase N/A · 1 location(s) · IRCCS San Raffaele · NCT06694792
AI-powered Early Detection for Pancreatic Cancer Via Non-contrast CT in Opportunistic Screening Cohort
Phase N/A · 3 location(s) · Changhai Hospital · NCT06638866
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonanc
Phase 4 · 51 location(s) · Guerbet · NCT04373564
Hyperpolarized C Pyruvate Magnetic Resonance Imaging, and Blood-Based Biomarkers for Early Detection of Pancreatic Adeno
Phase N/A · 8 location(s) · Memorial Sloan Kettering Cancer Center · NCT06305728
Preventing Postoperative Complications in Patients Undergoing High-risk Pancreatoduodenectomy With a Bundle Approach Inc
Phase 4 · 1 location(s) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC · NCT07262957
UCSF PANC Cyst Registry
Phase N/A · 1 location(s) · University of California, San Francisco · NCT04291651
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
Phase 1 · 30 location(s) · Eli Lilly and Company · NCT07213791
Using Radiogenomics to Predict Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas
Phase N/A · 3 location(s) · H. Lee Moffitt Cancer Center and Research Institute · NCT04275557
A Liquid Biopsy for Pancreatic Cancer Early-detection and Disease Monitoring
Phase N/A · 1 location(s) · Università Vita-Salute San Raffaele · NCT07700992
Advanced Therapies for Liver Metastases
Phase N/A · 1 location(s) · IRCCS San Raffaele · NCT04622423
Endocrine, Metabolic, Inflammatory Biomarkers to Identify Highgrade Dysplasia/invasive Carcinoma in Patients with IPMN o
Phase N/A · 1 location(s) · IRCCS San Raffaele · NCT06706700
Management of Pancreatic Cystic Lesions Using Artificial Intelligence Based on EUS and Multimodal Data
Phase N/A · 2 location(s) · Huazhong University of Science and Technology · NCT07463872
Biophotonic Nanoparticle-enabled Laser Blood Test for Early Detection of Pancreatic Cancer
NA · 1 location(s) · Fondazione Policlinico Universitario Campus Bio-Medico · NCT07659639
Exploring Biomarkers of the Carcinogenesis of Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas
Phase N/A · 1 location(s) · Zhejiang University · NCT05433935
Endoscopic Ultrasound-Guided Radiofrequency Ablation for Pancreatic Cystic Neoplasms and Pancreatic Neuroendocrine Tumor
NA · 1 location(s) · Institute for Clinical and Experimental Medicine · NCT07536087
Artificial Intelligence-powered Low-Dose Computed Tomography for Screening of Pancreatic Cancer
Phase N/A · 5 location(s) · Changhai Hospital · NCT07117045
AI-Powered Precision Decision-Making for Pancreatic Diseases
Phase N/A · 1 location(s) · Changhai Hospital · NCT07439757
Ultra-High Resolution Optical Coherence Tomography in Detecting Micrometer Sized Early Stage Pancreatic Cancer in Partic
NA · 1 location(s) · Ohio State University Comprehensive Cancer Center · NCT03711890
Intraductal Papillary Mucinous Neoplasm (IPMN) Database - A Tool to Predict Pancreatic Cancer
Phase N/A · 1 location(s) · St Vincent's Hospital Melbourne · NCT05117723
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.